Treatment of acute leukaemia and medullary inhibition in aseptic environment
Bláha, M.; Vanásek, J.; Mĕrka, V.; Erichleb, M.; Splino, M.; Siroký, O.; Mazák, J.; Hrncír, Z.; Malý, J.
Casopis Lekaru Ceskych 117(22-23): 698-701
1978
ISSN/ISBN: 0008-7335 PMID: 98234 Document Number: 134807
Document emailed within 1 workday
Related Documents
Blăha, M.; Mazák, J.; Vanásek, J.; Hrncír, Z.; Mĕrka, V.; Stroký, O. 1977: Treatment of acute bone-marrow suppression in an aseptic environment Vnitrni Lekarstvi 23(8): 769-772Stopera, S.A.; Ray, M. 1989: Expression and distribution of aphidicolin-induced fragile sites in chronic myeloid leukaemia, acute lymphocytic leukaemia and acute myeloid leukaemia Cytobios 60(241): 103-109
Hann, I.; Vora, A.; Richards, S.; Hill, F.; Gibson, B.; Lilleyman, J.; Kinsey, S.; Mitchell, C.; Eden, O.B. 2000: Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia Leukemia 14(3): 356-363
Tobelem, G.; Harousseau, J.L.; Lemercier, N.; Flandrin, G.; Jacquillat, C.; Schaison, G. 1978: Initial medullary necrosis during acute lymphoblastic leukemia. Value of medullary scintigraphy La Nouvelle Presse Medicale 7(32): 2865
Kondratenko, P.G.; Kon'kova, M.V.; Dzhansyz, I.N. 2011: Surgical treatment of an acute non-biliary aseptic necrotizing pancreatitis Klinichna Khirurhiia 2: 18-22
Wöhrer, S.; Rabitsch, W.; Shehata, M.; Kondo, R.; Esterbauer, H.; Streubel, B.; Sillaber, C.; Raderer, M.; Jaeger, U.; Zielinski, C.; Valent, P. 2007: Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone Anticancer Research 27(6b): 3837-3841
Rodoman, G.V.; Shalaeva, T.I.; Sosikova, N.L. 2012: The miniinvasive treatment of the aseptic fluid collections by the acute necrotizing pancreatitis Khirurgiia 3: 43-48
Löwenberg, B. 1997: Treatment of acute myelogenous leukaemia Journal of Internal Medicine. Supplement 740: 17-22
Amiraslanov, I.A.; Borisov, I.V. 2014: Treatment of patient with femur chronic medullary osteomyelitis and foreign bodies in the medullary canal Khirurgiia 6: 71-73
Willoughby, M.L. 1972: Recent progress in the treatment of childhood acute leukaemia Nouvelle Revue Francaise d'Hematologie 12(3): 365-371
Kudva, G.C.; Chandy, M.; Raghupathy, P.; Dennison, D.; Srivastava, A.; Bhushan, V.; Singh, R. 1994: Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen Indian Journal of Cancer 31(2): 78-85
Labar, B.; Nemet, D.; Minigo, H.; Bogdanić, V.; Jaksić, B.; Malesević, M.; Mrsić, M. 1989: Aclarubicin in the treatment of de-novo acute myelocytic leukaemia Bone Marrow Transplantation 4(Suppl): 45-46
Liesner, R.; Goldstone, A.H. 1997: Treatment of childhood and adult acute lymphoblastic leukaemia Journal of Internal Medicine. Suppl 740: 29-36
Amiel, J.L. 1977: Simple propositions in the treatment of acute lymphoblastic leukaemia La Nouvelle Presse Medicale 6(29): 2595-2597
Melo, J.V.; Goldman, J.M. 1992: Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia Leukemia 6(8): 786-790
Fadilah, S.-A.-W.; Raja-Zahratul-Azma, R.-S.; Leong, C.-F. 2006: Extensive myelofibrosis responsive to treatment for acute erythroblastic leukaemia Malaysian Journal of Pathology 28(1): 55-58
Cabanillas, F. 1981: Current status of the treatment of recurrent acute myeloblastic leukaemia in adults Sangre 26(5b): 885-889
McCulloch, E.A.; Minden, M.D.; Curtis, J.E. 1990: The influence of growth regulation on treatment strategy for acute myeloblastic leukaemia Cancer Surveys 9(1): 169-198
Lowenthal, R.M.; Marsden, K.A.; Newman, N.M.; Baikie, M.J.; Campbell, S.N. 1978: Normal infant after treatment of acute myeloid leukaemia in pregnancy with daunorubicin Australian and New Zealand Journal of Medicine 8(4): 431-432
Nemet, D.; Labar, B.; Bogdanić, V.; Hauptman, E.; Jaksić, B.; Minigo, H.; Sertić, D.; Mrsić, M.; Pavletić, Z.; Kovacević, J. 1989: High dose cytosine arabinoside in the treatment of adult acute myelogenous leukaemia Bone Marrow Transplantation 4(Suppl 3): 42-44